52
ROCHESTER, N.Y. — Kodak is expanding its pharmaceutical offerings with the introduction of four new products. These products are variations of “phosphate buffered saline” and “water for injection,” which are essential ingredients for laboratory research.
Kodak is working to offer more pharmaceuticals in the future.
“The expansion of Kodak’s existing unregulated key starting materials business to include high-quality, reliable Class 1 regulated laboratory reagents is a milestone in our long-term plan,” said Jim Continenza, Kodak’s Executive Chairman and CEO.
For more information, visit Kodak’s website here.
